GAS5 is downregulated, acts as a TSG in RCC and suppresses proliferation, invasion and migration of ccRCC cells [232]; however, no correlation between GAS5 levels and clinicopathological parameters of RCC has been reported [35,208]. Here, GAS5 is linked to nonpapillary renal cell carcinoma.